According to this study, the global Humanized Models market size will reach US$ 562 million by 2031.
A humanized model is a biological model that uses genetic engineering or cell transplantation technology to reconstruct human genes, cells or immune systems in animals, and can better simulate the occurrence and development of human diseases. This model breaks through the limitations of traditional animal models that differ from humans in terms of immune system, drug metabolism, etc. It plays an irreplaceable role in new drug development, antibody drug evaluation, cell therapy verification and precision medicine research, and is gradually becoming an important tool for cutting-edge biomedical research.
United States market for Humanized Models is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Humanized Models is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Humanized Models is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Humanized Models players cover The Jackson Laboratory, Crown Bioscience., Atlantis Bioscience, Taconic Biosciences, Champions Oncology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淗umanized Models Industry Forecast鈥� looks at past sales and reviews total world Humanized Models sales in 2024, providing a comprehensive analysis by region and market sector of projected Humanized Models sales for 2025 through 2031. With Humanized Models sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Humanized Models industry.
This Insight Report provides a comprehensive analysis of the global Humanized Models landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Humanized Models portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Humanized Models market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Humanized Models and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Humanized Models.
This report presents a comprehensive overview, market shares, and growth opportunities of Humanized Models market by product type, application, key players and key regions and countries.
Segmentation by Type:
Humanized Organ Models
Humanized Cell Models
Humanized Gene Models
Others
Segmentation by Application:
Pharmaceuticals
Biological Research
Education
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
The Jackson Laboratory
Crown Bioscience.
Atlantis Bioscience
Taconic Biosciences
Champions Oncology
Horizon Discovery
Hera Biolabs
Genoway
Ingenious Targeting Laboratory
Axenis
Harbour Antibodies
Cyagen
Inotiv
Oncodesign Services
Pharmatest Services
GemPharmatech
Shanghai Model Organisms
Saiye Biological Information
Biocytogen
Vitalstar Biotechnology
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Humanized Models Market Size (2020-2031)
2.1.2 Humanized Models Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Humanized Models by Country/Region (2020, 2024 & 2031)
2.2 Humanized Models Segment by Type
2.2.1 Humanized Organ Models
2.2.2 Humanized Cell Models
2.2.3 Humanized Gene Models
2.2.4 Others
2.3 Humanized Models Market Size by Type
2.3.1 Humanized Models Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Humanized Models Market Size Market Share by Type (2020-2025)
2.4 Humanized Models Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Biological Research
2.4.3 Education
2.4.4 Others
2.5 Humanized Models Market Size by Application
2.5.1 Humanized Models Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Humanized Models Market Size Market Share by Application (2020-2025)
3 Humanized Models Market Size by Player
3.1 Humanized Models Market Size Market Share by Player
3.1.1 Global Humanized Models Revenue by Player (2020-2025)
3.1.2 Global Humanized Models Revenue Market Share by Player (2020-2025)
3.2 Global Humanized Models Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Humanized Models by Region
4.1 Humanized Models Market Size by Region (2020-2025)
4.2 Global Humanized Models Annual Revenue by Country/Region (2020-2025)
4.3 Americas Humanized Models Market Size Growth (2020-2025)
4.4 APAC Humanized Models Market Size Growth (2020-2025)
4.5 Europe Humanized Models Market Size Growth (2020-2025)
4.6 Middle East & Africa Humanized Models Market Size Growth (2020-2025)
5 Americas
5.1 Americas Humanized Models Market Size by Country (2020-2025)
5.2 Americas Humanized Models Market Size by Type (2020-2025)
5.3 Americas Humanized Models Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Humanized Models Market Size by Region (2020-2025)
6.2 APAC Humanized Models Market Size by Type (2020-2025)
6.3 APAC Humanized Models Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Humanized Models Market Size by Country (2020-2025)
7.2 Europe Humanized Models Market Size by Type (2020-2025)
7.3 Europe Humanized Models Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Humanized Models by Region (2020-2025)
8.2 Middle East & Africa Humanized Models Market Size by Type (2020-2025)
8.3 Middle East & Africa Humanized Models Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Humanized Models Market Forecast
10.1 Global Humanized Models Forecast by Region (2026-2031)
10.1.1 Global Humanized Models Forecast by Region (2026-2031)
10.1.2 Americas Humanized Models Forecast
10.1.3 APAC Humanized Models Forecast
10.1.4 Europe Humanized Models Forecast
10.1.5 Middle East & Africa Humanized Models Forecast
10.2 Americas Humanized Models Forecast by Country (2026-2031)
10.2.1 United States Market Humanized Models Forecast
10.2.2 Canada Market Humanized Models Forecast
10.2.3 Mexico Market Humanized Models Forecast
10.2.4 Brazil Market Humanized Models Forecast
10.3 APAC Humanized Models Forecast by Region (2026-2031)
10.3.1 China Humanized Models Market Forecast
10.3.2 Japan Market Humanized Models Forecast
10.3.3 Korea Market Humanized Models Forecast
10.3.4 Southeast Asia Market Humanized Models Forecast
10.3.5 India Market Humanized Models Forecast
10.3.6 Australia Market Humanized Models Forecast
10.4 Europe Humanized Models Forecast by Country (2026-2031)
10.4.1 Germany Market Humanized Models Forecast
10.4.2 France Market Humanized Models Forecast
10.4.3 UK Market Humanized Models Forecast
10.4.4 Italy Market Humanized Models Forecast
10.4.5 Russia Market Humanized Models Forecast
10.5 Middle East & Africa Humanized Models Forecast by Region (2026-2031)
10.5.1 Egypt Market Humanized Models Forecast
10.5.2 South Africa Market Humanized Models Forecast
10.5.3 Israel Market Humanized Models Forecast
10.5.4 Turkey Market Humanized Models Forecast
10.6 Global Humanized Models Forecast by Type (2026-2031)
10.7 Global Humanized Models Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Humanized Models Forecast
11 Key Players Analysis
11.1 The Jackson Laboratory
11.1.1 The Jackson Laboratory Company Information
11.1.2 The Jackson Laboratory Humanized Models Product Offered
11.1.3 The Jackson Laboratory Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 The Jackson Laboratory Main Business Overview
11.1.5 The Jackson Laboratory Latest Developments
11.2 Crown Bioscience.
11.2.1 Crown Bioscience. Company Information
11.2.2 Crown Bioscience. Humanized Models Product Offered
11.2.3 Crown Bioscience. Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Crown Bioscience. Main Business Overview
11.2.5 Crown Bioscience. Latest Developments
11.3 Atlantis Bioscience
11.3.1 Atlantis Bioscience Company Information
11.3.2 Atlantis Bioscience Humanized Models Product Offered
11.3.3 Atlantis Bioscience Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Atlantis Bioscience Main Business Overview
11.3.5 Atlantis Bioscience Latest Developments
11.4 Taconic Biosciences
11.4.1 Taconic Biosciences Company Information
11.4.2 Taconic Biosciences Humanized Models Product Offered
11.4.3 Taconic Biosciences Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Taconic Biosciences Main Business Overview
11.4.5 Taconic Biosciences Latest Developments
11.5 Champions Oncology
11.5.1 Champions Oncology Company Information
11.5.2 Champions Oncology Humanized Models Product Offered
11.5.3 Champions Oncology Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Champions Oncology Main Business Overview
11.5.5 Champions Oncology Latest Developments
11.6 Horizon Discovery
11.6.1 Horizon Discovery Company Information
11.6.2 Horizon Discovery Humanized Models Product Offered
11.6.3 Horizon Discovery Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Horizon Discovery Main Business Overview
11.6.5 Horizon Discovery Latest Developments
11.7 Hera Biolabs
11.7.1 Hera Biolabs Company Information
11.7.2 Hera Biolabs Humanized Models Product Offered
11.7.3 Hera Biolabs Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Hera Biolabs Main Business Overview
11.7.5 Hera Biolabs Latest Developments
11.8 Genoway
11.8.1 Genoway Company Information
11.8.2 Genoway Humanized Models Product Offered
11.8.3 Genoway Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Genoway Main Business Overview
11.8.5 Genoway Latest Developments
11.9 Ingenious Targeting Laboratory
11.9.1 Ingenious Targeting Laboratory Company Information
11.9.2 Ingenious Targeting Laboratory Humanized Models Product Offered
11.9.3 Ingenious Targeting Laboratory Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Ingenious Targeting Laboratory Main Business Overview
11.9.5 Ingenious Targeting Laboratory Latest Developments
11.10 Axenis
11.10.1 Axenis Company Information
11.10.2 Axenis Humanized Models Product Offered
11.10.3 Axenis Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Axenis Main Business Overview
11.10.5 Axenis Latest Developments
11.11 Harbour Antibodies
11.11.1 Harbour Antibodies Company Information
11.11.2 Harbour Antibodies Humanized Models Product Offered
11.11.3 Harbour Antibodies Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Harbour Antibodies Main Business Overview
11.11.5 Harbour Antibodies Latest Developments
11.12 Cyagen
11.12.1 Cyagen Company Information
11.12.2 Cyagen Humanized Models Product Offered
11.12.3 Cyagen Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Cyagen Main Business Overview
11.12.5 Cyagen Latest Developments
11.13 Inotiv
11.13.1 Inotiv Company Information
11.13.2 Inotiv Humanized Models Product Offered
11.13.3 Inotiv Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Inotiv Main Business Overview
11.13.5 Inotiv Latest Developments
11.14 Oncodesign Services
11.14.1 Oncodesign Services Company Information
11.14.2 Oncodesign Services Humanized Models Product Offered
11.14.3 Oncodesign Services Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Oncodesign Services Main Business Overview
11.14.5 Oncodesign Services Latest Developments
11.15 Pharmatest Services
11.15.1 Pharmatest Services Company Information
11.15.2 Pharmatest Services Humanized Models Product Offered
11.15.3 Pharmatest Services Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Pharmatest Services Main Business Overview
11.15.5 Pharmatest Services Latest Developments
11.16 GemPharmatech
11.16.1 GemPharmatech Company Information
11.16.2 GemPharmatech Humanized Models Product Offered
11.16.3 GemPharmatech Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 GemPharmatech Main Business Overview
11.16.5 GemPharmatech Latest Developments
11.17 Shanghai Model Organisms
11.17.1 Shanghai Model Organisms Company Information
11.17.2 Shanghai Model Organisms Humanized Models Product Offered
11.17.3 Shanghai Model Organisms Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Shanghai Model Organisms Main Business Overview
11.17.5 Shanghai Model Organisms Latest Developments
11.18 Saiye Biological Information
11.18.1 Saiye Biological Information Company Information
11.18.2 Saiye Biological Information Humanized Models Product Offered
11.18.3 Saiye Biological Information Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Saiye Biological Information Main Business Overview
11.18.5 Saiye Biological Information Latest Developments
11.19 Biocytogen
11.19.1 Biocytogen Company Information
11.19.2 Biocytogen Humanized Models Product Offered
11.19.3 Biocytogen Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Biocytogen Main Business Overview
11.19.5 Biocytogen Latest Developments
11.20 Vitalstar Biotechnology
11.20.1 Vitalstar Biotechnology Company Information
11.20.2 Vitalstar Biotechnology Humanized Models Product Offered
11.20.3 Vitalstar Biotechnology Humanized Models Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Vitalstar Biotechnology Main Business Overview
11.20.5 Vitalstar Biotechnology Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.